<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0015">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="ulist0010">
   <list-item id="u0010">
    <label>•</label>
    <p id="p0010">The computer-aided approach helps in defining the potential small molecules for therapeutic drugs against FIPV.</p>
   </list-item>
   <list-item id="u0015">
    <label>•</label>
    <p id="p0015">The compounds bound to FIPV 3CL
     <sup>pro</sup> active site and showed inhibitory effects in protease- and cell-based assays.
    </p>
   </list-item>
   <list-item id="u0020">
    <label>•</label>
    <p id="p0020">The best three compounds contained an acyl group, which fitted well in the binding pocket of FIPV 3CL
     <sup>pro</sup>.
    </p>
   </list-item>
   <list-item id="u0025">
    <label>•</label>
    <p id="p0025">All the candidate compounds could be optimized based on the Ro5 recommendation for further drug development.</p>
   </list-item>
  </list>
 </p>
</abstract>
